This deadline has passed and is no longer active
Apply for up to $3M to support continued development of your Phase II SBIR or STTR-funded heart, lung, blood, or sleep technology requiring approval or clearance by a Federal regulatory agency. The National Heart, Lung, and Blood Institute (NHLBI) SBIR Phase IIB Bridge and Small Market Awards programs aim to de-risk your technology and encourage partnerships between small businesses and investors and strategic partners.
Letters of Intent due May 19, 2017. Applications due June 19, 2017.
For more information, please read the full Notice: